Gregory Fraser
Stock Analyst at Truist Securities
(0.94)
# 883
Out of 4,667 analysts
34
Total ratings
36.84%
Success rate
-19.52%
Average return
Main Sectors:
Stocks Rated by Gregory Fraser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Hold | $60 → $62 | $55.10 | +12.52% | 8 | Oct 22, 2024 | |
| BHC Bausch Health Companies | Maintains: Hold | $8 → $7 | $8.19 | -14.53% | 2 | Jul 25, 2024 | |
| XAIR Beyond Air | Maintains: Buy | $10 → $8 | $0.49 | +1,527.34% | 6 | Apr 30, 2024 | |
| BTMD biote | Maintains: Buy | $10 → $9 | $6.06 | +48.51% | 2 | Jan 18, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6 → $7 | $8.41 | -16.77% | 4 | Nov 8, 2023 | |
| CORT Corcept Therapeutics | Maintains: Hold | $26 → $29 | $56.09 | -48.30% | 5 | Aug 3, 2023 | |
| NVCR NovoCure | Reiterates: Buy | $95 | $16.86 | +463.46% | 3 | Jun 6, 2023 | |
| EOLS Evolus | Maintains: Buy | $14 → $18 | $12.63 | +42.52% | 2 | May 26, 2023 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $45 → $40 | $10.18 | +292.93% | 2 | May 26, 2023 |
ANI Pharmaceuticals
Oct 22, 2024
Maintains: Hold
Price Target: $60 → $62
Current: $55.10
Upside: +12.52%
Bausch Health Companies
Jul 25, 2024
Maintains: Hold
Price Target: $8 → $7
Current: $8.19
Upside: -14.53%
Beyond Air
Apr 30, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $0.49
Upside: +1,527.34%
biote
Jan 18, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $6.06
Upside: +48.51%
Amneal Pharmaceuticals
Nov 8, 2023
Maintains: Buy
Price Target: $6 → $7
Current: $8.41
Upside: -16.77%
Corcept Therapeutics
Aug 3, 2023
Maintains: Hold
Price Target: $26 → $29
Current: $56.09
Upside: -48.30%
NovoCure
Jun 6, 2023
Reiterates: Buy
Price Target: $95
Current: $16.86
Upside: +463.46%
Evolus
May 26, 2023
Maintains: Buy
Price Target: $14 → $18
Current: $12.63
Upside: +42.52%
Arcutis Biotherapeutics
May 26, 2023
Maintains: Buy
Price Target: $45 → $40
Current: $10.18
Upside: +292.93%